Mepolizumab as an effective treatment in a case of hypophysitis in eosinophilic granulomatosis with polyangiitis

Granulomatosis or eosinophilic granulomatosis with polyangiitis (GPA/EGPA) can affect multiple organs resulting in heterogeneous symptoms and phenotypes. Pituitary gland dysfunction rarely occurs in GPA (1–3%) and even less in EGPA (two case reports). Here, we report a case of a 51-year-old female p...

Full description

Bibliographic Details
Main Authors: Jessy Chen, Tobias Alexander, Thula Walter-Rittel, Athanasia Ziagaki, Volker Siffrin
Format: Article
Language:English
Published: SAGE Publishing 2023-06-01
Series:Therapeutic Advances in Neurological Disorders
Online Access:https://doi.org/10.1177/17562864231182519
_version_ 1797796830959894528
author Jessy Chen
Tobias Alexander
Thula Walter-Rittel
Athanasia Ziagaki
Volker Siffrin
author_facet Jessy Chen
Tobias Alexander
Thula Walter-Rittel
Athanasia Ziagaki
Volker Siffrin
author_sort Jessy Chen
collection DOAJ
description Granulomatosis or eosinophilic granulomatosis with polyangiitis (GPA/EGPA) can affect multiple organs resulting in heterogeneous symptoms and phenotypes. Pituitary gland dysfunction rarely occurs in GPA (1–3%) and even less in EGPA (two case reports). Here, we report a case of a 51-year-old female patient with a four-year history of EGPA who presented with new polydipsia and polyuria. Laboratory testing and magnetic resonance imaging (MRI) confirmed pituitary gland dysfunction caused by a hypophysitis. Therapeutic adjustment with a switch from dupilumab to mepolizumab resulted in a decrease in clinical symptoms, inflammation in MRI, and normalization of C-reactive protein in serum. This case underlines hypophysitis as a rare organ involvement also in EGPA. Moreover, this case demonstrates the responsiveness of neuroinflammatory manifestations to the recently approved anti-interleukin-5 monoclonal antibody mepolizumab as a new potential treatment option.
first_indexed 2024-03-13T03:39:59Z
format Article
id doaj.art-e888b99cec054f3da9bf8e18b0a1fd11
institution Directory Open Access Journal
issn 1756-2864
language English
last_indexed 2024-03-13T03:39:59Z
publishDate 2023-06-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Neurological Disorders
spelling doaj.art-e888b99cec054f3da9bf8e18b0a1fd112023-06-23T11:33:34ZengSAGE PublishingTherapeutic Advances in Neurological Disorders1756-28642023-06-011610.1177/17562864231182519Mepolizumab as an effective treatment in a case of hypophysitis in eosinophilic granulomatosis with polyangiitisJessy ChenTobias AlexanderThula Walter-RittelAthanasia ZiagakiVolker SiffrinGranulomatosis or eosinophilic granulomatosis with polyangiitis (GPA/EGPA) can affect multiple organs resulting in heterogeneous symptoms and phenotypes. Pituitary gland dysfunction rarely occurs in GPA (1–3%) and even less in EGPA (two case reports). Here, we report a case of a 51-year-old female patient with a four-year history of EGPA who presented with new polydipsia and polyuria. Laboratory testing and magnetic resonance imaging (MRI) confirmed pituitary gland dysfunction caused by a hypophysitis. Therapeutic adjustment with a switch from dupilumab to mepolizumab resulted in a decrease in clinical symptoms, inflammation in MRI, and normalization of C-reactive protein in serum. This case underlines hypophysitis as a rare organ involvement also in EGPA. Moreover, this case demonstrates the responsiveness of neuroinflammatory manifestations to the recently approved anti-interleukin-5 monoclonal antibody mepolizumab as a new potential treatment option.https://doi.org/10.1177/17562864231182519
spellingShingle Jessy Chen
Tobias Alexander
Thula Walter-Rittel
Athanasia Ziagaki
Volker Siffrin
Mepolizumab as an effective treatment in a case of hypophysitis in eosinophilic granulomatosis with polyangiitis
Therapeutic Advances in Neurological Disorders
title Mepolizumab as an effective treatment in a case of hypophysitis in eosinophilic granulomatosis with polyangiitis
title_full Mepolizumab as an effective treatment in a case of hypophysitis in eosinophilic granulomatosis with polyangiitis
title_fullStr Mepolizumab as an effective treatment in a case of hypophysitis in eosinophilic granulomatosis with polyangiitis
title_full_unstemmed Mepolizumab as an effective treatment in a case of hypophysitis in eosinophilic granulomatosis with polyangiitis
title_short Mepolizumab as an effective treatment in a case of hypophysitis in eosinophilic granulomatosis with polyangiitis
title_sort mepolizumab as an effective treatment in a case of hypophysitis in eosinophilic granulomatosis with polyangiitis
url https://doi.org/10.1177/17562864231182519
work_keys_str_mv AT jessychen mepolizumabasaneffectivetreatmentinacaseofhypophysitisineosinophilicgranulomatosiswithpolyangiitis
AT tobiasalexander mepolizumabasaneffectivetreatmentinacaseofhypophysitisineosinophilicgranulomatosiswithpolyangiitis
AT thulawalterrittel mepolizumabasaneffectivetreatmentinacaseofhypophysitisineosinophilicgranulomatosiswithpolyangiitis
AT athanasiaziagaki mepolizumabasaneffectivetreatmentinacaseofhypophysitisineosinophilicgranulomatosiswithpolyangiitis
AT volkersiffrin mepolizumabasaneffectivetreatmentinacaseofhypophysitisineosinophilicgranulomatosiswithpolyangiitis